[go: up one dir, main page]

AU2003301758A8 - Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders - Google Patents

Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Info

Publication number
AU2003301758A8
AU2003301758A8 AU2003301758A AU2003301758A AU2003301758A8 AU 2003301758 A8 AU2003301758 A8 AU 2003301758A8 AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A AU2003301758 A AU 2003301758A AU 2003301758 A8 AU2003301758 A8 AU 2003301758A8
Authority
AU
Australia
Prior art keywords
manifacture
hyper
medicament
treatment
proliferative disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003301758A
Other versions
AU2003301758A1 (en
Inventor
Barry Hart
Jianqing Chen
Lin Yi
Jill E Wood
Yuanwei Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of AU2003301758A1 publication Critical patent/AU2003301758A1/en
Publication of AU2003301758A8 publication Critical patent/AU2003301758A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003301758A 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders Abandoned AU2003301758A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37833002P 2002-05-06 2002-05-06
US60/378,330 2002-05-06
PCT/US2003/013784 WO2004039359A2 (en) 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Publications (2)

Publication Number Publication Date
AU2003301758A1 AU2003301758A1 (en) 2004-05-25
AU2003301758A8 true AU2003301758A8 (en) 2004-05-25

Family

ID=32230080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301758A Abandoned AU2003301758A1 (en) 2002-05-06 2003-05-02 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders

Country Status (2)

Country Link
AU (1) AU2003301758A1 (en)
WO (1) WO2004039359A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
RS51752B (en) 2002-07-29 2011-12-31 Rigel Pharmaceuticals METHODS OF TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINDIAMINE COMPOUNDS
HRP20130602T1 (en) 2003-07-30 2013-07-31 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
DK1814878T3 (en) 2004-11-24 2012-05-07 Rigel Pharmaceuticals Inc SPIRO-2,4-PYRIMIDINE DIAMINE COMPOUNDS AND APPLICATIONS THEREOF
DE602006010979D1 (en) 2005-01-19 2010-01-21 Rigel Pharmaceuticals Inc PRODRUGS FROM 2,4-PYRIMIDIN DIAMIN COMPOUNDS AND THEIR USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004890D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2004039359A2 (en) 2004-05-13
AU2003301758A1 (en) 2004-05-25
WO2004039359A3 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
SI1474416T1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
AU2003300791A1 (en) Combination therapy for the treatment of pain
SI1487828T1 (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
GB0213869D0 (en) The treatment of pain
GB0219660D0 (en) Therapeutic use
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0223854D0 (en) Therapeutic treatment
AU2003215150A8 (en) Therapeutic compounds
ZA200405853B (en) Use of adapalene for the treatment of dermatological disorders
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003301758A8 (en) Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
GB0210464D0 (en) Therapeutic treatment
AU2003296545A8 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003209542A8 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
GB0201025D0 (en) The treatment of degenerative diseases
HRP20041159A2 (en) Combination for the treatment of airway disorders
GB0224328D0 (en) Combination therapy for respiratory disorders
GB0211413D0 (en) Combination therapy for respiratory disorders
IL164388A0 (en) Use of ranolazine for the preparation of a medicament for the treatment of arrhymias

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase